Inventor

KLEIN PETER S

US4 patents

⚠️ This page may combine multiple inventors who share the name “KLEIN PETER S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV PENNSYLVANIA

3 patents

US6441053B1Aug 27, 2002

Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same

UNIV PENNSYLVANIA37 citations84

US9452187B2Sep 27, 2016

In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs

UNIV PENNSYLVANIA3 citations71

US7378111B2May 27, 2008

Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease

UNIV PENNSYLVANIA1 citations41

KLEIN PETER S

1 patent

US9050315B2Jun 9, 2015

In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs

KLEIN PETER S1 citations43

KLEIN PETER S

UNIV PENNSYLVANIA

Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same

In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs

Regulation of GSK-3α activity for the treatment or prevention of Alzheimer&#39;s disease

KLEIN PETER S

In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs

Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease